(Q33652030)

28 July 2017

1 reference

title

Hypertriglyceridemia, insulin resistance, and the metabolic syndrome (English)

1 reference

28 July 2017

1 reference

1 reference

1 reference

1 reference

Grundy SM

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

American Journal of Cardiology

28 July 2017

published in

1 reference

28 July 2017

volume

83

1 reference

28 July 2017

issue

9B

1 reference

28 July 2017

page(s)

25F-29F

1 reference

Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Coronary heart disease in high-risk populations: lessons from Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Familial dyslipidaemic hypertension and other multiple metabolic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Quantification of coronary artery calcium using ultrafast computed tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Pathophysiology of insulin resistance in human disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Characterization of the insulin resistance of aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Abnormal glucocorticoid activity in subjects with risk factors for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Influence of body fat distribution on free fatty acid metabolism in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Isolated low HDL cholesterol. An insulin-resistant state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Insulin resistance and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Metabolic disturbances in hypertension: results from the population study 'men born in 1913'

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Prediction of Coronary Heart Disease Using Risk Factor Categories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Lipoproteins and the haemostatic system in atherothrombotic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Hypertriglyceridemia, but not hypercholesterolemia, is associated with the alterations of fibrinolytic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Investigations into the haemorheological significance of postprandial and fasting hypertriglyceridaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Insulin resistance syndrome and fibrinolytic activity: the northern Sweden MONICA study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Weight loss reduces abdominal fat and improves insulin action in middle-aged and older men with impaired glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Diet and exercise in the treatment of obesity: effects of 3 interventions on insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Changes in insulin sensitivity, glucose effectiveness, and B-cell function in regularly exercising subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Improvement of insulin sensitivity by short-term exercise training in hypertensive African American women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Glucose tolerance is improved after low- and high-intensity exercise in middle-age men and women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Exercise, glucose transport, and insulin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Troglitazone-induced hepatic failure leading to liver transplantation. A case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Fatal hepatotoxicity associated with troglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900211-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(99)00211-8

1 reference

release_torufbwqirfqpi4dlrugxfq3t4

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/torufbwqirfqpi4dlrugxfq3t4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference